Clinical Trial Update: Copeptin in the Diagnosis and Differential Diagnosis of Diabetes Insipidus. The CoSIP-Study

View source ↗

Summary

The CoSIP study evaluated copeptin as a diagnostic and differential diagnostic biomarker for diabetes insipidus; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Insipidus

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Diabetes Insipidus | Status: COMPLETED